Tangeretin

Tangeretin is a lipid of Polyketides (PK) class. Tangeretin is associated with abnormalities such as Cardiovascular Diseases, Complex Regional Pain Syndromes, Blood Clot, Hypercholesterolemia and Restenosis. The involved functions are known as Thrombus, Platelet function, Localized desquamation, Platelet Activation and Signal. Tangeretin often locates in Protoplasm, Cytoplasmic Granules, Cytoplasmic matrix, Plasma membrane and Blood. The associated genes with Tangeretin are GP6 gene, CDK2 gene, CDK6 gene, Tumor Suppressor Genes and CDH1 gene. The related lipids are Lipopolysaccharides. The related experimental models are Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Tangeretin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tangeretin?

Tangeretin is suspected in Complex Regional Pain Syndromes, Cardiovascular Diseases, Blood Clot, Hypercholesterolemia, Restenosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tangeretin

MeSH term MeSH ID Detail
Diabetes Mellitus D003920 90 associated lipids
Lung Neoplasms D008175 171 associated lipids
Reperfusion Injury D015427 65 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Parkinson Disease D010300 53 associated lipids
Per page 10 20 | Total 13

PubChem Associated disorders and diseases

What pathways are associated with Tangeretin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tangeretin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tangeretin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tangeretin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Tangeretin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tangeretin?

Mouse Model

Mouse Model are used in the study 'Methoxyflavones protect cells against endoplasmic reticulum stress and neurotoxin.' (Takano K et al., 2007) and Mouse Model are used in the study 'Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer.' (Bracke ME et al., 1999).

Transgenic Model

Transgenic Model are used in the study 'Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?' (Walle T, 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tangeretin

Download all related citations
Per page 10 20 50 100 | Total 222
Authors Title Published Journal PubMed Link
Ghali A et al. Thrombocytopenic Purpura Associated with Dietary Supplements Containing Citrus Flavonoids. Therapie pmid:26242500
pmid:
Kim H et al. Induction of apoptosis in human cervical carcinoma HeLa cells by polymethoxylated flavone-rich Citrus grandis Osbeck (Dangyuja) leaf extract. Food Chem. Toxicol. pmid:20538032
Mareel MM and De Mets M Anti-invasive activities of experimental chemotherapeutic agents. 1989 Crit. Rev. Oncol. Hematol. pmid:2686699
Bracke ME et al. The flavonoid tangeretin inhibits invasion of MO4 mouse cells into embryonic chick heart in vitro. 1989 May-Jun Clin. Exp. Metastasis pmid:2924447
Kandaswami C et al. Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. 1991 Cancer Lett. pmid:1998943
Bracke M et al. Effect of catechins and citrus flavonoids on invasion in vitro. 1991 Jan-Feb Clin. Exp. Metastasis pmid:1901781
Kandaswami C et al. Differential inhibition of proliferation of human squamous cell carcinoma, gliosarcoma and embryonic fibroblast-like lung cells in culture by plant flavonoids. 1992 Anticancer Drugs pmid:1450447
Le Bon AM et al. Inhibition of microsome-mediated binding of benzo[a]pyrene to DNA by flavonoids either in vitro or after dietary administration to rats. 1992 Chem. Biol. Interact. pmid:1643669
Nguyen TD and Canada AT Citrus flavonoids stimulate secretion by human colonic T84 cells. 1993 J. Nutr. pmid:8381480
Canivenc-Lavier MC et al. Evidence for tangeretin O-demethylation by rat and human liver microsomes. 1993 Xenobiotica pmid:8498088
Chaumontet C et al. Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells. 1994 Carcinogenesis pmid:7955073
Hirano T et al. Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. 1995 Br. J. Cancer pmid:8519648
Obermeier MT et al. Effects of bioflavonoids on hepatic P450 activities. 1995 Xenobiotica pmid:7483658
Canivenc-Lavier MC et al. Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver. 1996 Toxicology pmid:8931757
Chaumontet C et al. Lack of tumor-promoting effects of flavonoids: studies on rat liver preneoplastic foci and on in vivo and in vitro gap junctional intercellular communication. 1996 Nutr Cancer pmid:8910908
Canivenc-Lavier MC et al. Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P450 1A and 2B isozymes in rat liver. 1996 Toxicol. Appl. Pharmacol. pmid:8619243
Bracke ME et al. The E-cadherin/catenin complex in invasion and metastasis. 1996 Curr. Top. Microbiol. Immunol. pmid:8814984
Calomme M et al. Inhibition of bacterial mutagenesis by Citrus flavonoids. 1996 Planta Med. pmid:8693033
Chaumontet C et al. Flavonoids (apigenin, tangeretin) counteract tumor promoter-induced inhibition of intercellular communication of rat liver epithelial cells. 1997 Cancer Lett. pmid:9103293
Lake BG et al. Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human and rat liver slices. 1999 Mutat. Res. pmid:10095132
Rooprai HK et al. Influence of putative antiinvasive agents on matrix metalloproteinase secretion by human neoplastic glia in vitro. 1999 Ann. N. Y. Acad. Sci. pmid:10415799
Bracke ME et al. Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer. 1999 J. Natl. Cancer Inst. pmid:10050869
Breinholt V et al. Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. 1999 Xenobiotica pmid:10647909
Nielsen SE et al. Biotransformation of the citrus flavone tangeretin in rats. Identification of metabolites with intact flavane nucleus. 2000 Food Chem. Toxicol. pmid:10930694
Takanaga H et al. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. 2000 J. Pharmacol. Exp. Ther. pmid:10734174
Guo XL et al. [Studies on chemical constituents of processed green tangerine peel]. 2000 Zhongguo Zhong Yao Za Zhi pmid:12212096
Backman JT et al. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation. 2000 Clin. Pharmacol. Ther. pmid:10801247
Depypere HT et al. Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer. 2000 Eur. J. Cancer pmid:11056327
Ikegawa T et al. Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. 2000 Cancer Lett. pmid:11098080
Siess MH et al. Mechanisms involved in the chemoprevention of flavonoids. 2000 Biofactors pmid:11216486
Rong H et al. 8-Prenylnaringenin, the phytoestrogen in hops and beer, upregulates the function of the E-cadherin/catenin complex in human mammary carcinoma cells. 2001 Eur. J. Cell Biol. pmid:11675933
Datla KP et al. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. 2001 Neuroreport pmid:11726811
Rooprai HK et al. Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro. 2001 Neuropathol. Appl. Neurobiol. pmid:11299000
Delaney B et al. Immunotoxicity of a standardized citrus polymethoxylated flavone extract. 2001 Food Chem. Toxicol. pmid:11527568
Ortuño A et al. Increasing resistance against Phytophthora citrophthora in tangelo Nova fruits by modulating polymethoxyflavones levels. 2002 J. Agric. Food Chem. pmid:11982408
Williams JA et al. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. 2002 Drug Metab. Dispos. pmid:12386134
Wang MS et al. Inhibition of 11beta-hydroxysteroid dehydrogenase in guinea pig kidney by three bioflavonoids and their interactions with gossypol. 2002 Acta Pharmacol. Sin. pmid:11860745
Brack ME et al. The citrus methoxyflavone tangeretin affects human cell-cell interactions. 2002 Adv. Exp. Med. Biol. pmid:12083457
Pan MH et al. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. 2002 Carcinogenesis pmid:12376477
Delaney B et al. Genetic toxicity of a standardized mixture of citrus polymethoxylated flavones. 2002 Food Chem. Toxicol. pmid:11955667
Rodriguez J et al. Effects of several flavonoids on the growth of B16F10 and SK-MEL-1 melanoma cell lines: relationship between structure and activity. 2002 Melanoma Res. pmid:11930105
Almada-Ruiz E et al. Fungicidal potential of methoxylated flavones from citrus for in vitro control of Colletotrichum gloeosporioides, causal agent of anthracnose disease in tropical fruits. 2003 Pest Manag. Sci. pmid:14620052
Breinholt VM et al. In vitro metabolism of genistein and tangeretin by human and murine cytochrome P450s. 2003 Pharmacol. Toxicol. pmid:12828569
Nogata Y et al. Effect of extraction method on the concentrations of selected bioactive compounds in mandarin juice. 2003 J. Agric. Food Chem. pmid:14640582
Stroheker T et al. Estrogenic effects of food wrap packaging xenoestrogens and flavonoids in female Wistar rats: a comparative study. 2003 Jul-Aug Reprod. Toxicol. pmid:12849853
del Río JA et al. Changes in the levels of polymethoxyflavones and flavanones as part of the defense mechanism of Citrus sinensis (cv. Valencia Late) fruits against Phytophthora citrophthora. 2004 J. Agric. Food Chem. pmid:15053528
Soars MG et al. An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes. 2004 Drug Metab. Dispos. pmid:14709631
Stroheker T et al. Steroid activities comparison of natural and food wrap compounds in human breast cancer cell lines. 2004 Food Chem. Toxicol. pmid:15110097
Yáñez J et al. Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: relationship between structure and activity. 2004 Nutr Cancer pmid:15489212
Kurowska EM et al. Modulation of HepG2 cell net apolipoprotein B secretion by the citrus polymethoxyflavone, tangeretin. 2004 Lipids pmid:15134141
Kurowska EM and Manthey JA Hypolipidemic effects and absorption of citrus polymethoxylated flavones in hamsters with diet-induced hypercholesterolemia. 2004 J. Agric. Food Chem. pmid:15137829
Liu L et al. Phytochemical analysis of anti-atherogenic constituents of Xue-Fu-Zhu-Yu-Tang using HPLC-DAD-ESI-MS. 2004 Chem. Pharm. Bull. pmid:15516749
Honda Y et al. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. 2004 Br. J. Pharmacol. pmid:15504753
Mungur R et al. Metabolite fingerprinting in transgenic Nicotiana tabacum altered by the Escherichia coli glutamate dehydrogenase gene. 2005 J. Biomed. Biotechnol. pmid:16046826
Nagase H et al. Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities. 2005 Biochem. Biophys. Res. Commun. pmid:16253614
Wang X et al. Preparative isolation and purification of polymethoxylated flavones from Tangerine peel using high-speed counter-current chromatography. 2005 J Chromatogr A pmid:16196149
Van Slambrouck S et al. Tangeretin inhibits extracellular-signal-regulated kinase (ERK) phosphorylation. 2005 FEBS Lett. pmid:15757658
Whitman SC et al. Nobiletin, a citrus flavonoid isolated from tangerines, selectively inhibits class A scavenger receptor-mediated metabolism of acetylated LDL by mouse macrophages. 2005 Atherosclerosis pmid:15585197
Martínez Conesa C et al. Treatment of metastatic melanoma B16F10 by the flavonoids tangeretin, rutin, and diosmin. 2005 J. Agric. Food Chem. pmid:16104801
Vanhoecke BW et al. A safety study of oral tangeretin and xanthohumol administration to laboratory mice. 2005 Jan-Feb In Vivo pmid:15796161
Park YJ et al. [6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells. 2006 Yonsei Med. J. pmid:17066513
Ujiki MB et al. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. 2006 Mol. Cancer pmid:17196098
Hamada M et al. TCDD-induced CYP1A1 expression, an index of dioxin toxicity, is suppressed by flavonoids permeating the human intestinal Caco-2 cell monolayers. 2006 J. Agric. Food Chem. pmid:17090139
Weber B et al. Liquid chromatography/mass spectrometry and liquid chromatography/nuclear magnetic resonance as complementary analytical techniques for unambiguous identification of polymethoxylated flavones in residues from molecular distillation of orange peel oils (Citrus sinensis). 2006 J. Agric. Food Chem. pmid:16417279
Li C et al. [Chemical constituents from roots of Ficus hirta]. 2006 Zhongguo Zhong Yao Za Zhi pmid:16570800
Li LJ et al. [Chemical constituents from roots of Platycodon grandiflorum]. 2006 Zhongguo Zhong Yao Za Zhi pmid:17144467
Abe S et al. Chemopreventive effects of orange peel extract (OPE). II: OPE inhibits atypical hyperplastic lesions in rodent mammary gland. 2007 J Med Food pmid:17472462
Fan K et al. Chemopreventive effects of orange peel extract (OPE). I: OPE inhibits intestinal tumor growth in ApcMin/+ mice. 2007 J Med Food pmid:17472461
Yi LZ et al. Quality control and discrimination of pericarpium citri reticulatae and pericarpium citri reticulatae viride based on high-performance liquid chromatographic fingerprints and multivariate statistical analysis. 2007 Anal. Chim. Acta pmid:17386812
Li S et al. Efficient and scalable method in isolation of polymethoxyflavones from orange peel extract by supercritical fluid chromatography. 2007 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:17035106
Walle UK and Walle T Bioavailable flavonoids: cytochrome P450-mediated metabolism of methoxyflavones. 2007 Drug Metab. Dispos. pmid:17709371
Green CO et al. Determination of polymethoxylated flavones in peels of selected Jamaican and Mexican citrus (Citrus spp.) cultivars by high-performance liquid chromatography. 2007 Biomed. Chromatogr. pmid:17080505
Ohtani H et al. Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells. 2007 Pharm. Res. pmid:17492365
Johann S et al. Antimicrobial activity of wax and hexane extracts from Citrus spp. peels. 2007 Mem. Inst. Oswaldo Cruz pmid:17923995
Nishimuta H et al. Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. 2007 Biopharm Drug Dispos pmid:17876860
Wang D et al. Identification of polymethoxylated flavones from green tangerine peel (Pericarpium Citri Reticulatae Viride) by chromatographic and spectroscopic techniques. 2007 J Pharm Biomed Anal pmid:17367982
Mertens-Talcott SU et al. Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells. 2007 J. Agric. Food Chem. pmid:17348674
Zhou DY et al. Characterization of polymethoxylated flavones in Fructus aurantii by liquid chromatography with atmospheric pressure chemical ionization combined with tandem mass spectrometry. 2007 J Pharm Biomed Anal pmid:17291708
Eguchi A et al. Suppressive effects of demethylated metabolites of nobiletin on phorbol ester-induced expression of scavenger receptor genes in THP-1 human monocytic cells. 2007 Biofactors pmid:18806314
Malemud CJ Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways. 2007 Curr Opin Pharmacol pmid:17398158
Buisson D et al. Biotransformation of polymethoxylated flavonoids: access to their 4'-O-demethylated metabolites. 2007 J. Nat. Prod. pmid:17559266
Walle T Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? 2007 Semin. Cancer Biol. pmid:17574860
Choi SY et al. Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. 2007 Biol. Pharm. Bull. pmid:17409518
Takano K et al. Methoxyflavones protect cells against endoplasmic reticulum stress and neurotoxin. 2007 Am. J. Physiol., Cell Physiol. pmid:16971492
Chen KH et al. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. 2007 Biochem. Pharmacol. pmid:17067555
Morley KL et al. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. 2007 Cancer Lett. pmid:17197076
Quintieri L et al. Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. 2008 Biochem. Pharmacol. pmid:18191104
Bracke ME et al. Plant polyphenolics as anti-invasive cancer agents. 2008 Anticancer Agents Med Chem pmid:18288920
Wang Z et al. Validated reversed phase LC method for quantitative analysis of polymethoxyflavones in citrus peel extracts. 2008 J Sep Sci pmid:18095294
Sekiguchi H et al. Suppressive Effects of Selected Food Phytochemicals on CD74 Expression in NCI-N87 Gastric Carcinoma Cells. 2008 J Clin Biochem Nutr pmid:18818744
Akao Y et al. Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells. 2008 Bioorg. Med. Chem. pmid:18282757
Satsu H et al. Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals. 2008 J. Agric. Food Chem. pmid:18540626
Miller EG et al. Inhibition of oral carcinogenesis by citrus flavonoids. 2008 Nutr Cancer pmid:18444138
Ho SC and Lin CC Investigation of heat treating conditions for enhancing the anti-inflammatory activity of citrus fruit (Citrus reticulata) peels. 2008 J. Agric. Food Chem. pmid:18683945
Xu GH et al. Minerals, phenolic compounds, and antioxidant capacity of citrus peel extract by hot water. 2008 J. Food Sci. pmid:18211343
Quintin J et al. Synthesis and biological evaluation of a series of tangeretin-derived chalcones. 2009 Bioorg. Med. Chem. Lett. pmid:19013795
Quintin J et al. Semisynthesis and antiproliferative evaluation of a series of 3'-aminoflavones. 2009 Bioorg. Med. Chem. Lett. pmid:19457664
Yi LZ et al. Fingerprinting alterations of secondary metabolites of tangerine peels during growth by HPLC-DAD and chemometric methods. 2009 Anal. Chim. Acta pmid:19664461
Arafa el-SA et al. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. 2009 Cancer Res. pmid:19903849